NTPC Limited Job Notification: NTPC is looking for Medical specialists (General Medicine, O&G, Pediatrics) and Medical Officers (GDMOs) for its Project/Station hospitals.
NTPC Limited has invited applications for the Medical Specialist and GDMO posts. Eligible and interested persons can apply for NTPC Limited Recruitment 2020 through the prescribed application format on or before 02 September 2020.
Important Date:
- Start Date for Submission of the Online Application: 18 August 2020
- Last Date for Submission of the Online Application: 02 September 2020
NTPC Limited Medical Specialist and GDMO Vacancy Details
- Medical Specialist: 23 Posts
- Medical (GDMO): 37 Posts
Eligibility Criteria for Medical Specialist and GDMO Job
Educational Qualification and Age Limit:
- Medical Specialist: MBBS with MD/MS in Medicine/O&G/Pediatrics. For E4 level: Minimum one year experience/practice after MD/MS. For E3 level: Fresh MD/MS qualified doctor. Age Limit: 37 years.
- Medical (GDMO): MBBS from recognized University/Institution. [Qualification should be recognized by MCI (Medical Council of India)]. Min. 02 years exp./practice after MBBS (Internship training shall not be counted as experience). Age Limit: 37 years.
Salary:
- Medical Specialist: E3: Rs. 60,000–Rs. 1,80,000 & E4: Rs. 70,000–Rs. 2,00,000.
- Medical (GDMO): E2: Rs. 50,000–Rs. 1,60,000.
Official Notification Download Here | |
Online Application Link | |
Official Website Link |
Download our Sarkari Naukri app from Play Store
How to Apply
Eligible and interested persons can apply for NTPC Limited Recruitment 2020 through the prescribed application format on or before 02 September 2020. Interested persons should log on to official website www.ntpccareers.net for applying. No other means/mode of application shall be accepted. Persons are required to possess a valid email ID. NTPC will not be responsible for bouncing back of any email sent to the persons.
Also Read Latest Employment News Articles
NHPC Recruitment 2020: Apply Online for 86 Trainee Engineer & Officer Posts
Comments
All Comments (0)
Join the conversation